Tarr Mark J
President & CEO
Tarr Mark J has filed 6 SEC Form 4 filings (15 transaction rows) across 1 company, with disclosures dating back to 2026. 6 of those filings fall inside the rolling window. Most recent filing: Aug 11, 2026.
On the most recent filing, Tarr Mark J is listed as President & CEO at Encompass Health Corp. Inside the rolling window, Tarr Mark J reported no open-market purchases and 2 open-market sales totaling $38.5M in EHC. The largest disclosed transaction in the window is a sale of 173,148 EHC shares on Aug 10, 2026, worth $21.7M.
Companies traded
Other insiders at EHC
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$38.5M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Tarr Mark J made?
Tarr Mark J has filed 6 SEC Form 4 filings (15 transaction rows) across 1 company since 2026.
Which companies does Tarr Mark J trade?
Tarr Mark J has filed SEC Form 4 disclosures for 1 company, including EHC.
When was Tarr Mark J's most recent SEC Form 4 filing?
Tarr Mark J's most recent SEC Form 4 filing on Tracefour is dated Aug 11, 2026.
What is Tarr Mark J's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Tarr Mark J is listed as President & CEO.
What is Tarr Mark J's total buy and sell value in the current window?
Inside the rolling retention window, Tarr Mark J bought $0 and sold $38.5M based on SEC Form 4 filings.
What was Tarr Mark J's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 173,148 EHC shares on 2026-08-10, worth $21.7M, per SEC Form 4 filings.